BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 16393302)

  • 41. Proton pump inhibitor and clopidogrel interaction: the case for watchful waiting.
    Tan VP; Yan BP; Hunt RH; Wong BC
    J Gastroenterol Hepatol; 2010 Aug; 25(8):1342-7. PubMed ID: 20659222
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice.
    Lanas A; García-Rodríguez LA; Polo-Tomás M; Ponce M; Alonso-Abreu I; Perez-Aisa MA; Perez-Gisbert J; Bujanda L; Castro M; Muñoz M; Rodrigo L; Calvet X; Del-Pino D; Garcia S
    Am J Gastroenterol; 2009 Jul; 104(7):1633-41. PubMed ID: 19574968
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Statements of the Malaysian Society of Gastroenterology & Hepatology and the National Heart Association of Malaysia task force 2012 working party on the use of antiplatelet therapy and proton pump inhibitors in the prevention of gastrointestinal bleeding.
    Tan HJ; Mahadeva S; Menon J; Ng WK; Zainal Abidin I; Chan FK; Goh KL; ;
    J Dig Dis; 2013 Jan; 14(1):1-10. PubMed ID: 23134105
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nonsteroidal antiinflammatory drugs and risk of gastrointestinal bleeding among patients on hemodialysis.
    Jankovic SM; Aleksic J; Rakovic S; Aleksic A; Stevanovic I; Stefanovic-Stoimenov N; Radosavljevic M; Kostic M; Tesic D; Petrovic B
    J Nephrol; 2009; 22(4):502-7. PubMed ID: 19662606
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-effectiveness of proton pump inhibitor cotherapy in patients taking long-term, low-dose aspirin for secondary cardiovascular prevention.
    Saini SD; Schoenfeld P; Fendrick AM; Scheiman J
    Arch Intern Med; 2008 Aug; 168(15):1684-90; discussion 1691. PubMed ID: 18695083
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiplatelet agents do not impact the hospital course in patients with gastrointestinal bleeding.
    John BK; Arramraju S; Shalomov A; Sison C; Rubin M
    J Clin Gastroenterol; 2011 Aug; 45(7):583-9. PubMed ID: 21293292
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiplatelet and anticoagulant therapy in patients with gastrointestinal bleeding: an 86-year-old woman with peptic ulcer disease.
    Almadi MA; Barkun A; Brophy J
    JAMA; 2011 Dec; 306(21):2367-74. PubMed ID: 22045703
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Therapy for prevention of upper gastrointestinal bleeding in patients receiving anti-thrombotic therapy].
    Satoh K; Sugano K
    Nihon Rinsho; 2014 Jul; 72(7):1325-30. PubMed ID: 25163330
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study.
    Li L; Geraghty OC; Mehta Z; Rothwell PM;
    Lancet; 2017 Jul; 390(10093):490-499. PubMed ID: 28622955
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Perioperative acute upper gastrointestinal haemorrhage in older patients with hip fracture: incidence, risk factors and prevention.
    Fisher L; Fisher A; Pavli P; Davis M
    Aliment Pharmacol Ther; 2007 Feb; 25(3):297-308. PubMed ID: 17217452
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adherence to gastroprotection and the risk of NSAID-related upper gastrointestinal ulcers and haemorrhage.
    van Soest EM; Sturkenboom MC; Dieleman JP; Verhamme KM; Siersema PD; Kuipers EJ
    Aliment Pharmacol Ther; 2007 Jul; 26(2):265-75. PubMed ID: 17593072
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Only full adherence to proton pump inhibitors protects against drug-induced upper gastrointestinal bleeding.
    Ruiz B; Aguirre U; Estany-Gestal A; Rodella L; Ruiz P; Figueiras A; Carvajal A; Ibáñez L; Conforti A; de Pancorbo MM; Vidal X; Martin LH; Aguirre C
    Eur J Clin Pharmacol; 2018 Nov; 74(11):1503-1511. PubMed ID: 30043109
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Do proton pump inhibitors attenuate the effect of aspirin on platelet aggregation? A randomized crossover study.
    Adamopoulos AB; Sakizlis GN; Nasothimiou EG; Anastasopoulou I; Anastasakou E; Kotsi P; Karafoulidou A; Stergiou GS
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):163-8. PubMed ID: 19568178
    [TBL] [Abstract][Full Text] [Related]  

  • 55. NSAID-induced gastrointestinal damage: current clinical management and recommendations for prevention.
    Lanas A; Ferrandez A
    Chin J Dig Dis; 2006; 7(3):127-33. PubMed ID: 16808792
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Platelet antiaggregation and hemorrhagic risk in hemodialysis].
    Sánchez Perales MC; Vázquez E; García Cortés MJ; Borrego FJ; Borrego J; Pérez del Barrio P; Liébana A; Gil JM; Viedma G; Pérez Bañasco V
    Nefrologia; 2002; 22(5):456-62. PubMed ID: 12497747
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aspirin in cardiology--benefits and risks.
    Björklund L; Wallander MA; Johansson S; Lesén E
    Int J Clin Pract; 2009 Mar; 63(3):468-77. PubMed ID: 19222632
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictors of inappropriate utilization of intravenous proton pump inhibitors.
    Afif W; Alsulaiman R; Martel M; Barkun AN
    Aliment Pharmacol Ther; 2007 Mar; 25(5):609-15. PubMed ID: 17305762
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding.
    Khurram Z; Chou E; Minutello R; Bergman G; Parikh M; Naidu S; Wong SC; Hong MK
    J Invasive Cardiol; 2006 Apr; 18(4):162-4. PubMed ID: 16729401
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Statins are associated with lower risk of gastrointestinal bleeding in patients with unstable coronary syndromes: analysis of the Orbofiban in Patients with Unstable coronary Syndromes-Thrombolysis In Myocardial Infarction 16 (OPUS-TIMI 16) trial.
    Atar S; Cannon CP; Murphy SA; Rosanio S; Uretsky BF; Birnbaum Y
    Am Heart J; 2006 May; 151(5):976.e1-6. PubMed ID: 16644315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.